Management

Blue Books of Neurology

Volumn 34, Issue C, 2010, Pages 474-488

  Moro, Elena ^a   Vidailhet, Marie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880838692     PISSN: 1877184X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-1-4160-6641-5.00027-1     Document Type: Chapter

References (130)

1. Hamani, C., Moro, E., Surgery for other movement disorders—dystonia, tics. Curr Opin Neurol 20 (2007), 470–476.
2. Jankovic, J., Brin, M.F., Therapeutic uses of botulinum toxin. N Engl J Med 324 (1991), 1186–1194.
3. Ichinose, H., Ohye, T., Takashi, E., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8 (1994), 236–242.
4. Svetel, M., Kozic, D., Stefanoval, E., et al. Dystonia in Wilson's disease. Mov Disord 16 (2001), 719–723.
5. Jankovic, J., Treatment of dystonia. Lancet Neurol 5 (2006), 864–872.
6. Mariotti, P., Fasano, A., Contarino, M.F., et al. Management of status dystonicus: our experience and review of the literature. Mov Disord 22 (2007), 963–968.
7. Balash, Y., Giladi, N., Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 11 (2004), 361–370.
8. Jankovic, J., Esquenazi, A., Fehling, D., et al. Evidence-based review of patient reported outcomes with botulinum toxin type A. Clin Neuropharmacol 27 (2004), 234–244.
9. Albanese, A., Barnes, M.P., Bhatia, K.P., et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 13 (2006), 433–444.
10. Consky, E.S., Lang, A.E., Clinical assessments of patients with cervical dystonia. Jankovic, J., Hallet, M., (eds.) Therapy with Botulinum Toxin, 1994, Marcel Dekker, New York, 211–237.
11. Comella, C.L., Stebbins, G.T., Goetz, C.G., et al. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12 (1997), 570–575.
12. Tsui, J.K., Hayward, M., Mak, E.K., Schulzer, M., Botulinum toxin type B in the treatment of cervical dystonia: a pilot study. Neurology 45 (1995), 2109–2110.
13. Comella, C.L., Leurgans, S., Wuu, J., et al. Dystonia study group. Rating scales for dystonia: a multicenter assessment. Mov Disord 18 (2003), 303–312.
14. Burke, R.E., Fahn, S., Marsden, C.D., et al. Validity and reliability of a rating scale for the primary torsion dystonia. Neurology 35 (1985), 73–77.
15. Cano, S.J., Warner, T.T., Linacre, J.M., et al. Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CID-58). Neurology 63 (2004), 1629–1633.
16. Muller, J., Wissel, J., Kemmler, G., et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75 (2004), 749–753.
17. Jankovic, J., Dystonia: medical therapy and botulinum toxin. Adv Neurol 94 (2004), 275–286.
18. Mejia, N.I., Vuong, K.D., Jankovic, J., Long-term botulinum toxin efficacy, safety and immunogenicity. Mov Disord 20 (2005), 592–597.
19. Simpson, D.M., Blitzer, A., Brashear, A., et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008), 1699–1706.
20. Odergren, T., Hjaltason, H., Kaakkola, S., et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64 (1998), 6–12.
21. Ranoux, D., Gury, C., Fondarai, J., et al. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72 (2002), 459–462.
22. Bihari, K., Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Curr Med Res Opin 21 (2005), 433–438.
23. Marchetti, A., Magar, R., Findley, L., et al. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study. Mov Disord 20 (2005), 937–944.
24. Jost, W.H., Blümel, J., Grafe, S., Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs 67 (2007), 669–683.
25. Truong, D., Duane, D.D., Jankovic, J., et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20 (2005), 783–791.
26. Chapman, M.A., Barron, R., Tanis, D.C., et al. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther 29 (2007), 1325–1537.
27. Costa, J., Espírito-Santo, C., Borges, A., et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev, 1, 2005 CD003633.
28. Tarsy, D., Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 12 (1997), 100–102.
29. Hsiung, G.Y., Das, S.K., Ranawaya, R., et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17 (2002), 1288–1293.
30. Haussermann, P., Marczoch, S., Klinger, C., et al. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. Mov Disord 19 (2004), 303–308.
31. Skogseid, I.M., Kerty, E., The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 12 (2005), 163–170.
32. Comella, C.L., Buchman, A.S., Tanner, C.M., et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 42 (1992), 878–882.
33. Jankovic, J., Needle EMG guidance is rarely required. Muscle Nerve 24 (2001), 1568–1570.
34. Brin, M.F., Lew, M.F., Adler, C.H., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type-A resistant cervical dystonia. Neurology 53 (1999), 1431–1438.
35. Lew, M.F., Adornato, B.T., Duane, D.D., et al. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49 (1997), 701–707.
36. Brashear, A., Lew, M.F., Dykstra, D.D., et al. Safety and efficacy of Neurobloc (botulinum toxin type B) in type A responsive cervical dystonia. Neurology 53 (1999), 1439–1446.
37. Costa, J., Espírito-Santo, C., Borges, A., et al. Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev, 1, 2005 CD004315.
38. Jankovic, J., Orman, J., Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37 (1987), 616–623.
39. Calace, P., Cortese, G., Piscopo, R., et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol 13 (2003), 331–336.
40. Costa, J., Espírito-Santo, C., Borges, A., et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev, 1, 2005 CD004900.
41. Jankovic, J., Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening. J Neurol Neurosurg Psychiatry, 60, 1996, 704.
42. Quirk, J.A., Sheean, G.L., Marsden, C.D., Lees, A.J., Treatment of nonoccupational limb and trunk dystonia with botulinum toxin. Mov Disord 11 (1996), 377–383.
43. Wissel, J., Kabus, C., Wenzel, R., Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 61 (1996), 172–175.
44. Cole, R., Hallet, M., Cohen, L.G., Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Mov Disord 10 (1995), 466–471.
45. Molloy, F.M., Shill, H.A., Kaelin-Lang, A., Karp, B.I., Accuracy of muscle localization without EMG: implications for treatment of limb dystonia. Neurology 58 (2002), 805–807.
46. Chen, R., Karp, B.I., Goldstein, S.R., et al. Effect of muscle activity immediately after botulinum toxin injection for writer's cramp. Mov Disord 14 (1999), 307–312.
47. Kruisdijk, J.J., Koelman, J.H., Ongerboer de Visser, B.W., et al. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 78 (2007), 264–270.
48. Djebbari, R., du Montcel, S.T., Sangla, S., et al. Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin. J Neurol Neurosurg Psychiatry 75 (2004), 1688–1691.
49. Tassorelli, C., Mancini, F., Balloni, L., et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord 21 (2006), 2240–2243.
50. Sheean, G., Restoring balance in focal limb dystonia with botulinum toxin. Disabil Rehabil 29 (2007), 1778–1788.
51. Harwood, G., Hierons, R., Fletcher, N.A., Mardsen, C.D., Lessons from a remarkable family with dopa-responsive dystonia. J Neurol Neurosurg Psychiatry 57 (1994), 460–463.
52. Nygaard, T.G., Marsedn, C.D., Duvoisin, R.C., Dopa-responsive dystonia. Adv Neurol 50 (1988), 377–384.
53. Lang, A.E., Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neurol 50 (1988), 561–570.
54. Marsden, C.D., Marion, M.H., Quinn, N., The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 47 (1984), 1166–1173.
55. Dewey, R.B. Jr., Muenter, M.D., Kishore, A., Snow, B.J., Long-term follow-up of levodopa responsiveness in generalized dystonia. Arch Neurol 55 (1998), 1320–1323.
56. Karp, B.I., Goldstein, S.R., Chen, R., et al. An open trial of clozapine for dystonia. Mov Disord 14 (1999), 652–657.
57. Trugman, J.M., Leadbetter, R., Zalis, M.E., et al. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 9 (1994), 441–446.
58. Kenney, C., Hunter, C., Jankovic, J., Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 22 (2007), 193–197.
59. Jankovic, J., Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 11 (1982), 41–47.
60. Burke, R.E., Fahn, S., Marsden, C.D., Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 36 (1986), 160–164.
61. Hoon, A.H. Jr., Freese, P.O., Reinhardt, E.M., et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 25 (2001), 55–58.
62. Anca, M.H., Falic Zaccai, T., Badarna, S., et al. Natural history of Oppenheim's dystonia (DYT-1) in Israel. J Child Neurol 18 (2003), 325–330.
63. Ford, B., Intrathecal baclofen in the treatment of dystonia. Adv Neurol 78 (1998), 199–210.
64. Albright, A.L., Barry, M.J., Shafton, D.H., Ferson, S.S., Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43 (2001), 652–657.
65. Richard, I., Menei, P., Intrathecal baclofen in the treatment of spasticity, dystonia and vegetative disorders. Acta Neurochir Suppl 97 (2007), 213–218.
66. Motta, F., Buonaguro, V., Stignani, C., The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 107:Suppl 1 (2007), 32–35.
67. Hering, S., Wenning, G.K., Seppi, K., et al. An open trial of levetiracetam for segmental and generalized dystonia. Mov Disord 22 (2007), 1649–1651.
68. Pina, M.A., Modrego, P.J., Dystonia induced by gabapentin. Ann Pharmacother 39 (2005), 380–382.
69. Berg, D., Becker, G., Naumann, M., Reiners, K., Morphine in tardive and idiopathic dystonia (short communication). J Neural Transm 108 (2001), 1035–1041.
70. Fox, S.H., Kellet, M., Moore, A.P., et al. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord 17 (2002), 145–149.
71. Priori, A., Pesenti, A., Cappellari, A., et al. Limb immobilization for the treatment of focal occupational dystonia. Neurology 57 (2001), 405–409.
72. Candia, V., Elbert, T., Altenmüller, E., et al. Constraint-induced movement therapy for focal hand dystonia in musicians. Lancet, 53, 1999, 42.
73. Ranawaya, R., Lang, A.E., Usefulness of a writing device in writer's cramp. Neurology 41 (1991), 1136–1138.
74. Zeuner, K.E., Bara-Jimenez, W., Noguchi, P.S., et al. Sensory training for patients with focal hand dystonia. Ann Neurol 51 (2002), 593–598.
75. Byl, N.N., Nagajaran, S., McKenzie, A.L., Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: a case series. Arch Phys Med Rehabil 84 (2003), 1505–1514.
76. Bleton, J.P., Role of the physiotherapist. Werner, T.T., Bressman, S.B., (eds.) Clinical Diagnosis and Management of Dystonia, 2007, Informa Healthcare, London, 223–233.
77. de Ajuriaguerra, J., Garcia Badaracco, J., Trillat, E., Soubiran, G., Traitement de la crampe des écrivains par la relaxation: le processus de guérison à partir de l'expérience tonique. L'Encéphale 45 (1956), 141–171.
78. Lang, A.E., Surgical treatment of dystonia. Adv Neurol 78 (1998), 185–198.
79. Tasker, R.R., Doorly, T., Yamashiro, K., Thalamotomy in generalized dystonia. Adv Neurol 50 (1988), 615–631.
80. Loher, T.J., Pohle, T., Krauss, J.K., Functional stereotactic surgery for treatment of cervical dystonia: review of the experience from the lesional era. Stereotact Funct Neurosurg 82 (2004), 1–13.
81. Taira, T., Ochiai, T., Goto, S., et al. Multimodal neurosurgical strategies for the management of dystonias. Acta Neurochir Suppl 99 (2006), 29–31.
82. Shibata, T., Hirashima, Y., Ikeda, H., et al. Stereotactic Voa-Vop complex thalamotomy for writer's cramp. Eur Neurol 53 (2005), 38–39.
83. Laitinen, L.V., Bergenheim, A.T., Hariz, M.I., Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76 (1992), 53–61.
84. Lozano, A.M., Kumar, R., Gross, R.E., et al. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord 12 (1997), 865–870.
85. Yoshor, D., Hamilton, W.J., Ondo, W., et al. Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery 48 (2001), 818–824.
86. Ford, B., Pallidotomy for generalized dystonia. Adv Neurol 94 (2004), 287–299.
87. Cohen-Gadol, A.A., Ahlskog, J.E., Matsumoto, J.Y., et al. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg 98 (2003), 1247–1254.
88. Bertrand, C.M., Molina-Negro, P., Selective peripheral denervation in 111 cases of spasmodic torticollis: rationale and results. Adv Neurol 50 (1988), 637–643.
89. Krauss, J.K., Loher, T.J., Pohle, T., et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry 72 (2002), 249–256.
90. Bittar, R.G., Yianni, J., Wang, S., et al. Deep brain stimulation for generalised dystonia and spasmodic torticollis. J Clin Neurosci 12 (2005), 12–16.
91. Hung, S.W., Hamani, C., Lozano, A.M., et al. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 68 (2007), 457–459.
92. Vidailhet, M., Vercueil, L., Houeto, J.L., et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352 (2005), 459–467.
93. Kupsch, A., Benecke, R., Muller, J., et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 355 (2006), 1978–1990.
94. Vidailhet, M., Vercueil, L., Houeto, J.L., et al. Bilateral, pallidal, deep-brain stimulation in primary generalized dystonia: a prospective 3 year follow-up study. Lancet Neurol 6 (2007), 223–229.
95. Kiss, Z.H., Doig-Beyaert, K., Eliasziw, M., et al. The Canadian multicenter trial of deep brain stimulation for cervical dystonia. Brain 130 (2007), 2879–2886.
96. Mueller, J., Skogseid, J.M., Benecke, R., et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 23 (2008), 131–134.
97. Vercueil, L., Pollak, P., Fraix, V., et al. Deep brain stimulation in the treatment of severe dystonia. J Neurol 248 (2001), 695–700.
98. Holloway, K.L., Baron, M.S., Brown, R., et al. Deep brain stimulation for dystonia: a meta-analysis. Neuromodulation 9 (2006), 253–261.
99. Ghika, J., Villemure, J.G., Miklossy, J., et al. Postanoxic generalized dystonia improved by bilateral Voa thalamic deep brain stimulation. Neurology 58 (2002), 311–313.
100. Fukaya, C., Katayama, Y., Kano, T., et al. Thalamic deep brain stimulation for writer's cramp. J Neurosurg 107 (2007), 977–982.
101. Krauss, J.K., Loher, T.J., Weigel, R., et al. Chronic stimulation of the globus pallidus internus for treatment of non-DYT1 generalized dystonia and choreoathetosis: 2-year follow up. J Neurosurg 98 (2003), 785–792.
102. Katayama, Y., Fukaya, C., Kobayashi, K., et al. Chronic stimulation of the globus pallidus internus for control of primary generalized dystonia. Acta Neurochir Suppl 87 (2003), 125–128.
103. Krause, M., Fogel, W., Kloss, M., et al. Pallidal stimulation for dystonia. Neurosurgery 55 (2004), 1361–1368.
104. Coubes, P., Cif, L., El Fertit, H., et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 101 (2004), 189–194.
105. Diamond, A., Shahed, J., Azher, S., et al. Globus pallidus deep brain stimulation in dystonia. Mov Disord 21 (2006), 692–695.
106. Goto, S., Yamada, K., Shimazu, H., et al. Impact of bilateral pallidal stimulation on DYT1-generalized dystonia in Japanese patients. Mov Disord 21 (2006), 1785–1787.
107. Foote, K.D., Sanchez, J.C., Okun, M.S., Staged deep brain stimulation for refractory craniofacial dystonia with blepharospasm: case report and physiology. Neurosurgery, 56, 2005, E415.
108. Houser, M., Waltz, T., Meige syndrome and pallidal deep brain stimulation. Mov Disord 20 (2005), 1203–1205.
109. Ostrem, J.L., Marks, W.J., Volz, M.M., et al. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord 22 (2007), 1885–1891.
110. Krauss, J.K., Loher, T.J., Pohle, T., et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry 72 (2002), 249–256.
111. Eltahawy, H.A., Saint-Cyr, J., Giladi, N., et al. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery 54 (2004), 613–619.
112. Eltahawy, H.A., Feinstein, A., Khan, F., et al. Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: a case report. Mov Disord 19 (2004), 969–972.
113. Trottenberg, T., Volkmann, J., Deuschl, G., et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 64 (2005), 344–346.
114. Franzini, A., Marras, C., Ferroli, P., et al. Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia: report of two cases. J Neurosurg 102 (2005), 721–725.
115. Damier, P., Thobois, S., Witjas, T., et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 64 (2007), 170–176.
116. Capelle, H.H., Grips, E., Weigel, R., et al. Posttraumatic peripherally-induced dystonia and multifocal deep brain stimulation: case report. Neurosurgery, 59, 2006, E702.
117. Castelnau, P., Cif, L., Valente, E.M., et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 57 (2005), 738–741.
118. Krause, M., Fogel, W., Tronnier, V., et al. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 21 (2006), 2255–2257.
119. Cif, L., Valente, E.M., Hemm, S., et al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 19 (2004), 724–727.
120. Magarinos-Ascone, C.M., Regidor, I., Martinez-Castrillo, J.C., et al. Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 76 (2005), 989–991.
121. Evidente, V.G., Lyons, M.K., Wheeler, M., et al. First case of X-linked dystonia-parkinsonism (“Lubag”) to demonstrate a response to bilateral pallidal stimulation. Mov Disord 22 (2007), 170–179.
122. Pillon, B., Ardouin, C., Dujardin, K., et al. Preservation of cognitive function in dystonia treated by pallidal stimulation. Neurology 66 (2006), 1556–1558.
123. Foncke, E.M., Schuurman, P.R., Speelman, J.D., Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 6 (2006), 142–143.
124. Pastor-Gomez, J., Hernando-Requejo, V., Luengo-Dos Santos, A., et al. Treatment of a case of generalized dystonia using subthalamic stimulation. Rev Neurol 37 (2003), 529–531.
125. Chou, K.L., Hurtig, H.I., Jaggi, J.L., et al. Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor. Mov Disord 20 (2005), 377–380.
126. Sun, B., Chen, S., Zhan, S., et al. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 97 (2007), 207–214.
127. Kleiner-Fisman, G., Liang, G.S., Moberg, P.J., et al. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 107 (2007), 29–36.
128. Tish, S., Rothwell, J.C., Limousin, P., et al. The physiological effects of pallidal deep brain stimulation in dystonia. IEEE Trans Neural Syst Rehabil Eng 15 (2007), 166–172.
129. Romito, L.M., Franzini, A., Perani, D., et al. Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology 68 (2007), 875–876.
130. Espay, A.J., Chen, R., Moro, E., Lang, A.E., Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation [Reply]. Neurology 69 (2007), 1062–1063.